| Literature DB >> 1647893 |
M J Lind1, S Gomm, A P Simmonds, L Ashcroft, A Kamthan, H Gurney, N Thatcher.
Abstract
A total of 45 patients with advanced non-small-cell lung cancer were treated with a combination of 1.5 g/m2 ifosfamide given on days 1-5 every 3 weeks for four courses with 3 million IU a2b-interferon (Intron A) given s.c. three times a week for 12 weeks. Nine objective responses were seen, including two complete responses (CRs) and seven partial responses (PRs). Haematological and non-haematological toxicities were generally mild and did not necessitate discontinuation of therapy.Entities:
Mesh：
Substances：
Year: 1991 PMID： 1647893 DOI： 10.1007/bf00689705
Source DB: PubMed Journal: Cancer Chemother Pharmacol ISSN： 0344-5704 Impact factor: 3.333